1-12 of 12
Laurence Albiges
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT089: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal bulk and single-cell RNAseq analyses of patient tumors identify biological correlates of response to PARP inhibitors and anti-PD-L1 therapy

Thibault Thomas-Bonafos, Julien Vibert, Arnaud Pagès, Léo Colmet-Daage, Roman Chabanon, Aurore Jeanson, Lambros Tselikas, Marlène Garrido, Clémence Hénon, Aurélien Parpaleix, Marianne Chasseriaud, Alice Bernard-Tessier, Nicolas Dorvault, Baptiste Bonnet, Clémence Astier, Anas Gazzah, Ronan Flippot, Natacha Naoun, Anna Patrikidou, Pernelle Lavaud, Aline Fuerea, Laurence Albiges, Yohann Loriot, Stéphane Champiat, Capucine Baldini, Fanny Bouquet, Nathalie Droin, Karim Fizazi, Damien Vasseur, Christophe Massard, Etienne Rouleau, Patricia Martin-Romano, Kaissa Ouali, Sophie Postel-Vinay
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): CT089.
https://doi.org/10.1158/1538-7445.AM2025-CT089
Published: 25 April 2025
View articletitled, Abstract CT089: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal bulk and single-cell RNAseq analyses of patient tumors identify biological correlates of response to PARP inhibitors and anti-PD-L1 therapy
Journal Articles

Abstract 4627: Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment

Nicolas Jacquin, Julien Masliah-Planchon, Guillaume Grisay, Ronan Flippot, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Oliver Delattre, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4627.
https://doi.org/10.1158/1538-7445.AM2024-4627
Published: 22 March 2024
View articletitled, Abstract 4627: Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment
Journal Articles

Abstract 5068: Clonal Hematopoiesis of indeterminate potential (CHIP) in patients with advanced solid tumors treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study

Julieta Elena Rodriguez, François Xavier Danlos, Alicia Larive, Aurelien Marabelle, Yohann Loriot, Caroline Robert, Laurence Albiges, Maxime Frelaut, Mihaela Aldea, Benjamin Besse, Michel Ducreux, Caroline Even, Jean Baptiste Micol, Santiago Ponce, Christophe Marzac, Nathalie Chaput, Christophe Massard, Capucine Baldini
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5068.
https://doi.org/10.1158/1538-7445.AM2024-5068
Published: 22 March 2024
View articletitled, Abstract 5068: Clonal Hematopoiesis of indeterminate potential (CHIP) in patients with advanced solid tumors treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study
Journal Articles

Abstract 6406: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal single-cell analysis of patient tumors identifies biological correlates of response to PARP inhibitors and anti-PD-L1 therapy

Julien Vibert, Clémence Hénon, Lambros Tselikas, Baptiste Bonnet, Arnaud Pagès, Alice Bernard-Tessier, Léo Colmet-Daage, Roman Chabanon, Nicolas Dorvault, Clémence Astier, Anas Gazzah, Aurore Jeanson, Aurélien Parpaleix, Ronan Flippot, Natacha Naoun, Anna Patrikidou, Pernelle Lavaud, Giulia Baciarello, Emeline Colomba, Alina Fuerea, Laurence Albiges, Christophe Massard, Santiago Ponce, Yohann Loriot, Stéphane Champiat, Capucine Baldini, Fanny Bouquet, Nathalie Droin, Karim Fizazi, Damien Vasseur, Patricia Martin-Romano, Etienne Rouleau, Kaïssa Ouali, Sophie Postel-Vinay
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6406.
https://doi.org/10.1158/1538-7445.AM2024-6406
Published: 22 March 2024
View articletitled, Abstract 6406: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal single-cell analysis of patient tumors identifies biological correlates of response to PARP inhibitors and anti-PD-L1 therapy
Journal Articles

Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy

Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, Bassam Janji, Andrés Tittarelli, Marie Boutet, Véronique Baud, Elodie Viry, Katy Billot, Arash Nanbakhsh, Thouraya Ben Safta, Catherine Richon, Sophie Ferlicot, Emmanuel Donnadieu, Sophie Couve, Betty Gardie, Florence Orlanducci, Laurence Albiges, Jerome Thiery, Daniel Olive, Bernard Escudier, Salem Chouaib
Journal: Cancer Research
Cancer Res (2022) 82 (8): 1671.
https://doi.org/10.1158/0008-5472.CAN-22-0500
Published: 15 April 2022
View articletitled, Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Open the PDF for Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy in another window
Journal Articles

Abstract 358: A prospective study of prostate cancer metastases identifies an androgen receptor activity-low, stemness program associated with resistance to androgen receptor axis inhibitors and unveils mechanisms of clonal evolution

Naoual Menssouri, Loic Poiraudeau, Carole Helissey, Ludovic Bigot, Jonathan Sabio, Tony Ibrahim, Claudio Nicotra, Maud Ngocamus, Lambros Tselikas, Thierry De Baere, Etienne Rouleau, Ludovic Lacroix, Anne Chaucherau, Luc Friboulet, Ronan Flippot, Giulia Baciarello, Laurence Albiges, Emeline Colomba, Pernelle Lavaud, Stefan Michiels, Aline Maillard, Antoine Italiano, Fabrice Barlesi, Jean-Charles Soria, Jean-Yves Scoazec, christophe Massard, Benjamin Besse, Fabrice André, Karim Fizazi, Daniel Gautheret, Yohann Loriot
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 358.
https://doi.org/10.1158/1538-7445.AM2021-358
Published: 01 July 2021
View articletitled, Abstract 358: A prospective study of prostate cancer metastases identifies an androgen receptor activity-low, stemness program associated with resistance to androgen receptor axis inhibitors and unveils mechanisms of clonal evolution
Journal Articles

Abstract CT243: A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors

Hans Hammers, Toni Choueiri, Elizabeth Plimack, Brian Rini, Robert Motzer, Lina Yin, Rodolfo Perini, Jaqueline Willemann-Rogerio, Laurence Albiges
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT243.
https://doi.org/10.1158/1538-7445.AM2021-CT243
Published: 01 July 2021
View articletitled, Abstract CT243: A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors
Journal Articles

Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments

Fabrice Barlesi, Stéphanie Foulon, Arnauld Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, Annabelle Stoclin, Mansouria Merad, Franck GriscelliI, Jean-Baptise Micol, Roger Sun, Thomas Nihouarn, Corinne Balleygier, Fabrice André, Florian Scotte, Benjamin Besse, Jean-Charles Soria, Laurence Albiges
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT403.
https://doi.org/10.1158/1538-7445.AM2020-CT403
Published: 15 August 2020
View articletitled, Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments
Journal Articles

Abstract CT153: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

Olivia Le Saux, Antoine Italiano, Dominique Spaeth, Pierre Heudel, Thomas Filleron, Laurence Albiges, Thomas Bachelot, Anthony Gonçalves, Jean-Yves Pierga, Fabrice Barlesi, Valérie Boige, Céleste Lebbé, Laurent Mortier, Jean Sébastien Frenel, Olivier Tredan, Marta Jimenez, François Legrand, Charles Ferte
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT153.
https://doi.org/10.1158/1538-7445.AM2018-CT153
Published: 01 July 2018
View articletitled, Abstract CT153: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
Journal Articles

Abstract CT006: Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic MET mutations. EORTC phase II trial 90101 “CREATE”

Patrick Schoffski, Agnieszka Wozniak, Bernard Escudier, Piotr Rutkowski, Alan Anthoney, Sebastian Bauer, Jozef Sufliarsky, Carla van Herpen, Lars Lindner, Viktor Grünwald, Branko Zakotnik, Evelyne Lerut, Sandrine Marréaud, Michela Lia, Tiana Raveloarivahy, Sandra Collette, Laurence Albiges
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT006.
https://doi.org/10.1158/1538-7445.AM2016-CT006
Published: 15 July 2016
View articletitled, Abstract CT006: Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic MET mutations. EORTC phase II trial 90101 “CREATE”
Journal Articles

ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy

Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, Bassam Janji, Andrés Tittarelli, Marie Boutet, Véronique Baud, Elodie Viry, Katy Billot, Arash Nanbakhsh, Thouraya Ben Safta, Catherine Richon, Sophie Ferlicot, Emmanuel Donnadieu, Sophie Couve, Betty Gardie, Florence Orlanducci, Laurence Albiges, Jerome Thiery, Daniel Olive, Bernard Escudier, Salem Chouaib
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6820–6832.
https://doi.org/10.1158/0008-5472.CAN-14-0303
Published: 30 November 2014
View articletitled, ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Open the PDF for ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 1746: The PREDICT (Personalised RNA Interference to Enhance the Delivery of Individualised Cytotoxic and Targeted Therapeutics) Approach to Biomarker Discovery in Renal Cell Carcinoma

Laurence Albiges, Marco Gerlinger, PREDICT consortium.
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1746.
https://doi.org/10.1158/1538-7445.AM2012-1746
Published: 15 April 2012
View articletitled, Abstract 1746: The PREDICT (Personalised RNA Interference to Enhance the Delivery of Individualised Cytotoxic and Targeted Therapeutics) Approach to Biomarker Discovery in Renal Cell Carcinoma